Dal Alert

Receive alerts from Dalhousie by text message.

X

David R. AndersonMD, FRCPC, FACP

Faculty of Medicine Dean, Professor

Division of Hematology , Department of Medicine , Department of Community Health and Epidemiology , Department of Pathology

Email: david.anderson@nshealth.ca
Phone: 902-473-8562 (Hematology) 902-494-8099 (Dean)
Fax: 902-473-4600 (Hematology)
Mailing Address: 
Division of Hematology
QEII - Bethune Building
Suite 430 Bethune Building
1276 South Park Street
Halifax, NS B3H 2Y9

Dean’s Office, Faculty of Medicine
Clinical Research Centre
Room C-205
5849 University Avenue
PO Box 15000
Halifax, NS B3H 4R2
 
Research Topics:
  • hematology
  • hematologic disorders
  • thromboembolic disorders

Biography

Dr. Anderson is a hematologist, professor of medicine, and as of July 1, 2015, he became dean of the Faculty of Medicine. His clinical interests are the care of patients with hematological disorders, particularly those with blood clotting problems.

Research interests

Dr. Anderson is a member of VECTOR (VEnous thromboembolic Clinical Trials and Outcomes Research), a national research group that focuses on patients with thromboembolic disorders. He also participates in a Maritime-based clinical research initiative that focuses on patient-oriented research.

"Equally safe"

A Halifax-based, cross-Canada study proves Aspirin is as effective as rivaroxaban in preventing blood clots after hip and knee replacement surgery.

The drugs are “equally safe,” says Dr. Anderson, but rivaroxaban costs dollars a day and Aspirin, pennies. “This really does help the patients and the overall health care system as a more affordable and equally safe and effective means of preventing blood clots.”

Read full story on Dal News - Mar. 6, 2018.

View more media items